JP2023504143A5 - - Google Patents
Info
- Publication number
- JP2023504143A5 JP2023504143A5 JP2022532095A JP2022532095A JP2023504143A5 JP 2023504143 A5 JP2023504143 A5 JP 2023504143A5 JP 2022532095 A JP2022532095 A JP 2022532095A JP 2022532095 A JP2022532095 A JP 2022532095A JP 2023504143 A5 JP2023504143 A5 JP 2023504143A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- nhr
- alkyl
- aryl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PLPCT/PL2019/000108 | 2019-11-27 | ||
| PL2019000108 | 2019-11-27 | ||
| PCT/EP2020/083597 WO2021105335A1 (en) | 2019-11-27 | 2020-11-27 | Piperidine-2, 6-dione derivatives which bind to cereblon, and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023504143A JP2023504143A (ja) | 2023-02-01 |
| JP2023504143A5 true JP2023504143A5 (cg-RX-API-DMAC10.html) | 2023-12-05 |
| JP7760167B2 JP7760167B2 (ja) | 2025-10-27 |
Family
ID=69024571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532095A Active JP7760167B2 (ja) | 2019-11-27 | 2020-11-27 | セレブロンに結合するピペリジン-2,6-ジオン誘導体、及びその使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230065745A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4065576A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7760167B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021105335A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022255888A1 (en) * | 2021-06-01 | 2022-12-08 | Captor Therapeutics S.A. | Targeted protein degradation using bifunctional compounds that bind ubiquitin ligase and target mcl-1 protein |
| CN113501807A (zh) * | 2021-06-10 | 2021-10-15 | 重庆科技学院 | 四氢苯并噻吩类化合物及药物组合物的制备方法和用途 |
| WO2023049919A1 (en) * | 2021-09-27 | 2023-03-30 | The Trustees Of The University Of Pennsylvania | Inhibitors of molluscum contagiosum infection and methods using the same |
| WO2023101556A1 (en) * | 2021-12-02 | 2023-06-08 | Rijksuniversiteit Groningen | Novel inhibitors of aspartate transcarbamoylase (atcase) and compositions, methods and uses related thereto. |
| AU2023403190A1 (en) * | 2022-12-02 | 2025-07-17 | Aten Porus Lifesciences Pvt. Ltd. | Adar1 inhibitors and methods of using the same |
| JP2025540970A (ja) * | 2022-12-06 | 2025-12-17 | キャプター セラピューティクス エス.エー. | ユビキチンリガーゼ及びターゲットmcl-1タンパク質に結合する二機能性化合物を使用するターゲティングされたタンパク質分解 |
| WO2024123195A1 (en) * | 2022-12-06 | 2024-06-13 | Captor Therapeutics S.A. | Targeted protein degradation using prodrugs of bifunctional compounds that bind ubiquitin ligase and target mcl-1 protein |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635517B1 (en) | 1996-07-24 | 1999-06-29 | Celgene Corp | Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines |
| JP2002105073A (ja) * | 2000-09-27 | 2002-04-10 | Shionogi & Co Ltd | 新規マトリックスメタロプロテアーゼ阻害剤 |
| US7323479B2 (en) | 2002-05-17 | 2008-01-29 | Celgene Corporation | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| CN1939922B (zh) * | 2005-09-27 | 2010-10-13 | 天津和美生物技术有限公司 | 可抑制细胞释放肿瘤坏死因子的5H-噻吩[3,4-c]吡咯-4,6-二酮衍生物 |
| AU2007290407A1 (en) | 2006-08-30 | 2008-03-06 | Celgene Corporation | 5-substituted isoindoline compounds |
| WO2008033562A2 (en) * | 2006-09-15 | 2008-03-20 | Xcovery, Inc. | Kinase inhibitor compounds |
| HUE035389T2 (en) | 2006-09-26 | 2018-05-02 | Celgene Corp | 5-substituted quinazolinone derivatives as anticancer agents |
| SG183257A1 (en) | 2010-02-11 | 2012-09-27 | Celgene Corp | Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same |
| CN109153644B (zh) | 2016-03-16 | 2022-10-21 | H·李·莫菲特癌症中心研究有限公司 | 用以增强效应t细胞功能的针对cereblon的小分子 |
| CN121974842A (zh) | 2016-05-10 | 2026-05-05 | C4医药公司 | 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体 |
| CN109562107A (zh) | 2016-05-10 | 2019-04-02 | C4医药公司 | 用于靶蛋白降解的杂环降解决定子体 |
| EP4717317A3 (en) | 2017-06-20 | 2026-06-03 | C4 Therapeutics, Inc. | N/o-linked degrons and degronimers for protein degradation |
| JP7258009B2 (ja) | 2017-07-10 | 2023-04-14 | セルジーン コーポレイション | 抗増殖化合物及びその使用方法 |
| CN118108706A (zh) | 2017-09-04 | 2024-05-31 | C4医药公司 | 戊二酰亚胺 |
| US10584133B2 (en) * | 2018-03-30 | 2020-03-10 | Biotheryx, Inc. | Thienopyrimidinone compounds |
-
2020
- 2020-11-27 WO PCT/EP2020/083597 patent/WO2021105335A1/en not_active Ceased
- 2020-11-27 US US17/780,894 patent/US20230065745A1/en active Pending
- 2020-11-27 JP JP2022532095A patent/JP7760167B2/ja active Active
- 2020-11-27 EP EP20838351.3A patent/EP4065576A1/en active Pending